Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Understanding hepatitis C.

C K Yim1

  • 1Division of Gastroenterology, Toronto Western Hospital, University Health Network, Toronto, Ontario.

CANNT Journal = Journal ACITN
|January 12, 2002
PubMed
Summary
This summary is machine-generated.

Chronic hepatitis C virus (HCV) infection impacts millions globally, particularly prevalent in dialysis patients. Early diagnosis and patient education are crucial for managing this slow-progressing liver disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical communication across the zinc tetrathiolate cluster in Escherichia coli Ada, a metalloactivated DNA repair protein.

Biochemistry·2001
Same author

Interferon-associated lymphocyte 2',5'-oligoadenylate synthetase in acute and chronic viral hepatitis.

Hepatology (Baltimore, Md.)·1989
See all related articles

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Nephrology

Background:

  • Chronic hepatitis C virus (HCV) infection affects over 170 million worldwide.
  • HCV is a leading cause for liver transplantation in Canada.
  • Prevalence in dialysis patients is high, estimated at 20-50%.

Purpose of the Study:

  • To summarize the epidemiology, diagnosis, and management of chronic HCV infection.
  • To highlight challenges in treating HCV in specific populations like dialysis patients.
  • To emphasize the importance of patient education and partnership in disease management.

Main Methods:

  • Review of diagnostic methods including anti-HCV, HCV RNA, ALT levels, and liver biopsy.
  • Discussion of transmission routes, particularly intravenous drug use.

Related Experiment Videos

  • Analysis of current treatment limitations and alternatives.

    • Main Results:

    • HCV infection progresses slowly, with 50-85% of acute cases becoming chronic.
    • Cirrhosis and hepatocellular carcinoma risk increase with disease duration.
    • Standard interferon and ribavirin treatment is often unsuitable for dialysis patients.

    Conclusions:

    • Liver biopsy remains the definitive diagnostic procedure for HCV.
    • Screening blood products may reduce HCV transmission in hemodialysis.
    • Patient education and collaborative care are essential for effective HCV management.